*FOR ORAL GLP-1 PILLS AS EFFECTIVE AS INJECTABLES SOURCE: National Institutes of Health (NIH), PubMed Central
CJC 1295 with DAC needs fewer injections while still keeping GH elevated, making it the more convenient option
Food and Drug Administration (FDA) include semaglutide (sold as Ozempic and Wegovy), liraglutide (Saxenda and Victoza), and tirzepatide (Zepbound), a dual GIP/GLP-1 receptor agonist
After reviewing literature and conducting a two-round Delphi survey with 42 experts, a consensus emerged that emphasizes prioritizing clinical symptoms in diagnosis, with serum B12 as a screening marker supported by methylmalonic acid or homocysteine levels for additional confirmation
Wish I wouldve gotten the stronger version
Chen L, Yin Z, Qin X, Zhu X, Chen X, Ding G, et al